Action Following the Discovery of a Global Association Between the Whole Genome and Adverse Event Risk in a Clinical Drug-Development Programme
Pharmaceutical Statistics - United Kingdom
doi 10.1002/pst.357
Full Text
Open PDFAbstract
Available in full text
Date
January 1, 2008
Authors
Publisher
Wiley